The following table lists adverse events that occurred at an incidence of 1% or more among eprosartan-treated patients who participated in placebo-controlled trials of 8 to 13 weeks' duration, using doses of 25 mg to 400 mg twice daily, and 400 mg to 1200 mg once daily. The overall incidence of adverse events reported with eprosartan mesylate (54.4%) was similar to placebo (52.8%).
Table 1. Adverse Events Reported by ≥ 1% of Patients Receiving Eprosartan Mesylate and Were More Frequent on Eprosartan than PlaceboEvent | Eprosartan (n = 1,202) % | Placebo (n = 352) % |
Body as a Whole | | |
Infection viral | 2 | 1 |
Injury | 2 | 1 |
Fatigue | 2 | 1 |
Gastrointestinal | | |
Abdominal pain | 2 | 1 |
Metabolic and Nutritional | | |
Hypertriglyceridemia | 1 | 0 |
Musculoskeletal | | |
Arthralgia | 2 | 1 |
Nervous System | | |
Depression | 1 | 0 |
Respiratory | | |
Upper respiratory tract infection | 8 | 5 |
Rhinitis | 4 | 3 |
Pharyngitis | 4 | 3 |
Coughing | 4 | 3 |
Urogenital | | |
Urinary tract infection | 1 | 0 |
The following adverse events were also reported at a rate of 1% or greater in patients treated with eprosartan, but were as, or more, frequent in the placebo group: headache, myalgia, dizziness, sinusitis, diarrhea, bronchitis, dependent edema, dyspepsia, and chest pain.
Facial edema was reported in five patients receiving eprosartan. Angioedema has been reported with other angiotensin II antagonists. Rare cases of rhabdomyolysis have been reported in patients receiving angiotensin II receptor blockers.
In addition to the adverse events above, potentially important events that occurred in at least two patients/subjects exposed to eprosartan or other adverse events that occurred in < 1% of patients in clinical studies are listed below. It cannot be determined whether events were causally related to eprosartan:
Body as a Whole: alcohol intolerance, asthenia, substernal chest pain, peripheral edema, fatigue, fever, hot flushes, influenza-like symptoms, malaise, rigors, pain;
Cardiovascular: angina pectoris, bradycardia, abnormal ECG, specific abnormal ECG, extrasystoles, atrial fibrillation, hypotension (including orthostatic hypotension), tachycardia, palpitations;
Gastrointestinal: anorexia, constipation, dry mouth, esophagitis, flatulence, gastritis, gastroenteritis, gingivitis, nausea, periodontitis, toothache, vomiting;
Hematologic: anemia, purpura;
Liver and Biliary: increased SGOT, increased SGPT;
Metabolic and Nutritional: increased creatine phosphokinase, diabetes mellitus, glycosuria, gout, hypercholesterolemia, hyperglycemia, hyperkalemia, hypokalemia, hyponatremia;
Musculoskeletal: arthritis, aggravated arthritis, arthrosis, skeletal pain, tendinitis, back pain;
Nervous System/Psychiatric: anxiety, ataxia, insomnia, migraine, neuritis, nervousness, paresthesia, somnolence, tremor, vertigo;
Resistance Mechanism: herpes simplex, otitis externa, otitis media, upper respiratory tract infection;
Respiratory: asthma, epistaxis;
Skin and Appendages: eczema, furunculosis, pruritus, rash, maculopapular rash, increased sweating;
Special Senses: conjunctivitis, abnormal vision, xerophthalmia, tinnitus;
Urinary: albuminuria, cystitis, hematuria, micturition frequency, polyuria, renal calculus, urinary incontinence;
Vascular: leg cramps, peripheral ischemia.